Abstract: An extended release pharmaceutical composition comprising micronized desvenlafaxine base, at least one pH modifier and at least one release controlling agent and its process for preparation. An extended release monolithic tablet is also provided. Further extended release tablets comprising micronized desvenlafaxine base; at least one pH modifier; at least one release controlling agent; and at least one binder; wherein, the proportion of binder in the tablet is greater than about 3.0% of the total weight of the tablet and wherein, the pH modifier is present in a proportion of more than about 15 parts for each of the 100 parts of the desvenlafaxine base is also provided. Also provided is process for preparation of extended release tablet.
Type:
Application
Filed:
May 9, 2011
Publication date:
February 7, 2013
Applicant:
ALEMBIC PHARMACEUTICALS LIMITED
Inventors:
Veerababu Ramabrahmmam Taduri, Girish Shantilal Achliya, Divyakumar Hemant Bora
Abstract: The present invention provides a new polymorph Form I of Teriflunomide sodium and a process for preparation thereof. The present invention provides an amorphous form of Teriflunomide sodium and a process for preparation thereof. The present invention provides a new polymorph Form I of Teriflunomide potassium and a process for preparation thereof. The present invention provides an amorphous form of Teriflunomide potassium and a process for preparation thereof. The present invention also provides particle size of Teriflunomide and its salts.
Type:
Application
Filed:
June 22, 2010
Publication date:
July 5, 2012
Applicant:
ALEMBIC PHARMACEUTICALS LIMITED
Inventors:
Ravi Ponnaiah, Samir Patel, Snehal Dhol, Vishal Ray
Abstract: The present invention relates to an improved process for the preparation of choline salt of fenofibric acid corresponding to formula (I). The present invention also provides crystalline polymorphic form of choline salt of fenofibric acid corresponding to formula (I) designated as form A.
Abstract: The present invention relates to improved process for the preparation of Duloxetine of formula (I) and salts thereof wherein said improvement takes place in step of condensation.
Type:
Application
Filed:
December 28, 2009
Publication date:
November 10, 2011
Applicant:
ALEMBIC PHARMACEUTICALS LIMITED
Inventors:
Ravi Ponnaiah, Ashok Prasad, Killol Patel, Hitarth Harshendu Acharya, Vilas Katore, Bhavik Shah